Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults.
- Resource Type
- Article
- Source
- Human Vaccines & Immunotherapeutics; 2021, Vol. 17 Issue 5, p1366-1373, 8p
- Subject
- Language
- ISSN
- 21645515